Quanterix (QTRX) Income from Continuing Operations (2017 - 2026)
Quanterix (QTRX) reported Income from Continuing Operations of 17541000.0 for Q1 2026, up 14.45% on a YoY basis from 15326231.05 in Q1 2025, and up 24.12% quarter-over-quarter from 23117000.0 in Q4 2025.
Quanterix (QTRX) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Quanterix has reported Income from Continuing Operations for 10 years, with the latest figure at 17541000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 14.45% year-over-year to 17541000.0; the trailing twelve-month figure through Mar 2026 stood at 104188000.0 (down 117.64% YoY), and the FY2025 full-year result was 107150000.0, down 178.09% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 17541000.0, up from 23117000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 5551000.0 in Q2 2023, with the low at 36550000.0 in Q3 2022.
- Historically, Income from Continuing Operations has averaged 17126529.41 across 5 years, with a median of 17541000.0 in 2026.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations jumped 81.63% — and 2025, when it tumbled 306.29%.
- Quanterix's Income from Continuing Operations stood at 18198000.0 in 2022, then soared by 51.57% to 8813000.0 in 2023, then plunged by 31.94% to 11628000.0 in 2024, then plunged by 98.8% to 23117000.0 in 2025, then rose by 24.12% to 17541000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 17541000.0 (Q1 2026), 23117000.0 (Q4 2025), and 33517000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Quanterix | 159.26 Mn | 59.99 Mn | 15.57 Mn | -17.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.54 Mn |
| Dec 31, 2025 | -23.12 Mn |
| Sep 30, 2025 | -33.52 Mn |
| Jun 30, 2025 | -30.01 Mn |
| Mar 31, 2025 | -20.50 Mn |
| Dec 31, 2024 | -11.63 Mn |
| Sep 30, 2024 | -8.35 Mn |
| Jun 30, 2024 | -7.39 Mn |
| Mar 31, 2024 | -11.16 Mn |
| Dec 31, 2023 | -8.81 Mn |
| Sep 30, 2023 | -6.72 Mn |
| Jun 30, 2023 | -5.55 Mn |
| Mar 31, 2023 | -7.27 Mn |
| Dec 31, 2022 | -18.20 Mn |
| Sep 30, 2022 | -36.55 Mn |
| Jun 30, 2022 | -26.91 Mn |
| Mar 31, 2022 | -17.92 Mn |
| Dec 31, 2021 | -17.89 Mn |
| Sep 30, 2021 | -15.66 Mn |
| Jun 30, 2021 | -11.90 Mn |